Pryor Cashman is representing Maxim Group LLC in its role as sole financial advisor to Regentis Biomaterials Ltd. in connection with a $95 million merger and de-SPAC transaction.

The deal, in which Regentis is merging with special purpose acquisition company (SPAC) OceanTech Acquisitions I Corp., is part of the company’s efforts to bring a tissue-regeneration treatment to U.S. and European markets. Regentis plans to go public after the deal.

Maxim Group is represented by Pryor Cashman Partner Ali Panjwani, co-chair of the Corporate Group and chair of the Securities + Corporate Finance Practice.

Learn more about the deal using the link below (subscription may be required).